Skip to main content
MONASH IVF GROUP LIMITED logo

MONASH IVF GROUP LIMITED — Investor Relations & Filings

Ticker · MVF ISIN · AU000000MVF3 LEI · 9845000F654B75F7D091 ASX Human health and social work activities
Open in API
Filings indexed 522 across all filing types
Latest filing 2026-05-19 Board/Management Inform…
Country AU Australia
Listing ASX MVF

About MONASH IVF GROUP LIMITED

https://www.monashivfgroup.com.au

Monash IVF Group Limited is a provider of assisted reproductive services and specialist women's health diagnostics. The organization delivers a comprehensive suite of fertility treatments, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and fertility preservation techniques such as egg and embryo freezing. Its clinical operations are supported by advanced diagnostic capabilities, encompassing pre-implantation genetic screening, prenatal testing, and specialized ultrasound imaging. The group focuses on the application of reproductive science and evidence-based medicine to address complex infertility challenges. Through a network of specialized clinics and laboratories, it provides integrated care pathways ranging from initial fertility assessments to donor programs and genetic counseling.

Recent filings

Filing Released Lang Actions
MVF Appoints Inaugural Chief Medical Officer 2 pages 183.7KB
Board/Management Information Classification · 92% confidence The text is a corporate announcement of an executive management appointment (the inaugural Chief Medical Officer), detailing the new role, background, and quotes. This aligns with ‘Board/Management Information’ (category for senior management changes).
2026-05-19 English
Monash IVF rejects revised non-binding indicative proposal 2 pages 258.6KB
M&A Activity Classification · 95% confidence The document is an ASX market announcement by Monash IVF Group Limited rejecting a revised non-binding indicative proposal for a takeover scheme. It discusses receipt of an acquisition proposal by way of Scheme of Arrangement, Board considerations, and rejection of the proposal. This clearly aligns with M&A Activity announcements related to takeover bids. Therefore, it should be classified as M&A Activity.
2026-04-19 English
Revised NBIO to acquire MVF 2 pages 220.8KB
M&A Activity Classification · 95% confidence The document is an ASX announcement dated 13 April 2026 regarding a revised non-binding indicative proposal to acquire Monash IVF Group Limited. It discusses the terms of a potential acquisition, including offer price, conditions, and the board's assessment. There are no financial statements, detailed financial analysis, or full report content. The document is a market announcement about a merger proposal, not a full merger filing or detailed financial report. It fits best under the category for M&A Activity announcements, which covers announcements and documents related to merger proposals or takeover bids.
2026-04-12 English
Notification of cessation of securities - MVF 4 pages 14.7KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for Monash IVF Group Limited. It provides specific information about securities that have ceased, including the number, reason for cessation, and updated issued capital figures. The document is a formal announcement to the ASX about changes in the company's securities, specifically the cessation of certain unquoted equity securities. This type of announcement corresponds to a report of changes in securities holdings or capital structure but does not describe new share issues or capital changes like stock splits. It is not a full financial report, earnings release, or management discussion. It is also not a director's dealing or major shareholding notification. The best fitting category is 'Transaction in Own Shares (POS)' as it reports cessation (lapse) of securities, which is a form of capital change related to the company's own securities. The document length is 3813 characters, which is consistent with an announcement rather than a full report. Therefore, the classification is POS with high confidence.
2026-04-07 English
Appointment of Interim CFO 1 page 202.3KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 26 March 2026 regarding the appointment of an Interim Chief Financial Officer for Monash IVF Group Limited. It details the interim appointment, background of the appointee, and transition arrangements. There is no financial data, no mention of a report or filing, and it concerns a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2026-03-25 English
1H26 Appendix 4D and Financial Report 26 pages 1.7MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Monash IVF Group Limited Appendix 4D Half-year report' and references the half-year ended 31 December 2025. It contains detailed financial data including revenue, EBITDA, EBIT, NPAT, segment analysis, and operational and financial review. It also includes directors' report, auditor's review report, consolidated financial statements, and notes. The document explicitly states it is an Interim Report for the half-year period, with comprehensive financial statements and analysis. The length is substantial (15,000 characters), and it contains actual financial data and management commentary. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2026-02-25 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.